Non Invasive Ventilation Versus Continuous Positive Airway Pressure After Extubation of Very Low Birth Weight Infants. (VNINS)
Primary Purpose
Neonatal Respiratory Failure
Status
Unknown status
Phase
Phase 3
Locations
Chile
Study Type
Interventional
Intervention
CPAP ventilation mode
NIPPV ventilation mode
Sponsored by
About this trial
This is an interventional treatment trial for Neonatal Respiratory Failure
Eligibility Criteria
Inclusion Criteria:
- Preterm with a weight less than 1501 g
- Gestational age less or equal to 34 weeks
- Preterm that meets extubation criteria after at least 2 hours and less than 14 days connected to mechanical ventilation
- Patient receiving methylxanthynes
Exclusion Criteria:
- Patient more than 14 days in mechanical ventilation
- Newborn with congenital cardiopathy
- Newborn with congenital malformation
- Newborn wirh chromosomopathy or genopathic disease
- Newborn with suspected gastrointestinal disease
- Newborn with neuromuscular disease or receiving muscle relaxants
- Lack or informed consent signed by parents or legal representative
Sites / Locations
- Hospital Clinico, Pontificia Universidad Catolica de ChileRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
CPAP ventilation mode
NIPPV ventilation mode
Arm Description
Once the patient is extubated, CPAP ventilation mode is inmediately administered in order to prevent reintubation
NIPPV: Non Invasive Ventilation mode is administered inmediately after extubation to prevent reintubation
Outcomes
Primary Outcome Measures
Extubation failure
The criteria for failure were met by at least 1 of the following:
pH less than 7.25 and PaCO2 over 65 mmHg; recurrent apnea more than 2 episodes per hour associated with bradycardia; during 4 hour continuous; 2 episodes of apnea that required bagand-mask ventilation in any time during the study; or a PaO2 less than 50 mm Hg with a fraction of inspired oxygen over 0.6.
Secondary Outcome Measures
Full Information
NCT ID
NCT01778829
First Posted
January 24, 2013
Last Updated
January 28, 2013
Sponsor
Pontificia Universidad Catolica de Chile
1. Study Identification
Unique Protocol Identification Number
NCT01778829
Brief Title
Non Invasive Ventilation Versus Continuous Positive Airway Pressure After Extubation of Very Low Birth Weight Infants.
Acronym
VNINS
Official Title
Nasal Intermittent Mandatory Ventilation Versus Continuous Positive Airway Pressure After Extubation of Very Low Birth Weight Infants of the NEOCOSUR Network.
Study Type
Interventional
2. Study Status
Record Verification Date
January 2013
Overall Recruitment Status
Unknown status
Study Start Date
December 2011 (undefined)
Primary Completion Date
May 2013 (Anticipated)
Study Completion Date
June 2013 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Pontificia Universidad Catolica de Chile
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to determine whether Nasal intermittent positive pressure ventilation (NIPPV) non synchronized is better than continuous positive airway pressure (NCPAP)in preventing extubation failure within 72 h, after extubation of very low birth weight infants at the NEOCOSUR Network.
Detailed Description
Is a Randomized trial to preterms infants <1500g and less than 34 weeks with RDS requiring machanical ventilation in the extubation period, randomized to receive NIPPV or NCPAP once extubation criteria were met. Parental written informed consent is required previous extubation. The failure rate is defined as the need for re-intubation and mechanical ventilation).
Exclusion criteria are: major congenital anomalies; presence of cardiovascular instability;intubation less than 2 hours; mechanical ventilation more than 14 days, using muscle relaxant, airway anomalies, consent not provided or refused.
Outcome measures:
The primary outcome was to assess the need for re-intubation within the first 72 hours after extubation in the 2 groups.
The criteria for failure were met by at least 1 of the following:
pH < 7.25 and PaCO2 > 65 mmHg; recurrent apnea more than 2 episodes per hour associated with bradycardia; during 4 hour continuous; 2 episodes of apnea that required bagand-mask ventilation in any time during the study; or a PaO2 < 50 mm Hg with a fraction of inspired oxygen > 0.6. The secondary outcomes concerning respiratory support were total duration on ETT ventilation, total duration on NCPAP, total duration on supplemental oxygen, incidence of pneumothorax,BPD and dead. Other outcomes included incidence of patent ductus arteriosus (PDA), necrotizing enterocolitis, intraventricular hemorrhage grades 3 and 4, retinopathy of prematurity stage 3, time to full feeds, and length of hospital stay.
Sample size calculations for the primary outcome: We estimated that there would be a more than 80% chance of detecting 43% difference between the groups (alpha 0.05) when samplesize (n) is 110 patients for each mode of treatment.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neonatal Respiratory Failure
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
220 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
CPAP ventilation mode
Arm Type
Active Comparator
Arm Description
Once the patient is extubated, CPAP ventilation mode is inmediately administered in order to prevent reintubation
Arm Title
NIPPV ventilation mode
Arm Type
Experimental
Arm Description
NIPPV: Non Invasive Ventilation mode is administered inmediately after extubation to prevent reintubation
Intervention Type
Procedure
Intervention Name(s)
CPAP ventilation mode
Intervention Description
Patients are ventilated through a nasal prong coneected to a ventilator that provides a continuous positive airway pressure
Intervention Type
Procedure
Intervention Name(s)
NIPPV ventilation mode
Intervention Description
Patients are ventilated through a nasal prong connected to a ventilator that provides a non synchronized intermittent positive pressure ventilation
Primary Outcome Measure Information:
Title
Extubation failure
Description
The criteria for failure were met by at least 1 of the following:
pH less than 7.25 and PaCO2 over 65 mmHg; recurrent apnea more than 2 episodes per hour associated with bradycardia; during 4 hour continuous; 2 episodes of apnea that required bagand-mask ventilation in any time during the study; or a PaO2 less than 50 mm Hg with a fraction of inspired oxygen over 0.6.
Time Frame
apnea rate and respiratory failure.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
2 Hours
Maximum Age & Unit of Time
14 Days
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Preterm with a weight less than 1501 g
Gestational age less or equal to 34 weeks
Preterm that meets extubation criteria after at least 2 hours and less than 14 days connected to mechanical ventilation
Patient receiving methylxanthynes
Exclusion Criteria:
Patient more than 14 days in mechanical ventilation
Newborn with congenital cardiopathy
Newborn with congenital malformation
Newborn wirh chromosomopathy or genopathic disease
Newborn with suspected gastrointestinal disease
Newborn with neuromuscular disease or receiving muscle relaxants
Lack or informed consent signed by parents or legal representative
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Alberto Estay, MD
Phone
56223546437
Email
albertoestay@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Alvaro Gonzalez, MD
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alberto Estay, MD
Organizational Affiliation
Pontificia Universidad Catolica de Chile
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Clinico, Pontificia Universidad Catolica de Chile
City
Santiago
Country
Chile
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alberto Estay, MD
Email
albertoestay@gmail.com
First Name & Middle Initial & Last Name & Degree
Alvaro Gonzalez, MD
Email
alvgonza@med.puc.cl
First Name & Middle Initial & Last Name & Degree
Alberto Estay, MD
12. IPD Sharing Statement
Citations:
PubMed Identifier
32388511
Citation
Estay AS, Mariani GL, Alvarez CA, Milet B, Agost D, Avila CP, Roldan L, Abdala DA, Keller R, Galletti MF, Gonzalez A; for the NEOCOSUR Neonatal Network. Randomized Controlled Trial of Nonsynchronized Nasal Intermittent Positive Pressure Ventilation versus Nasal CPAP after Extubation of VLBW Infants. Neonatology. 2020;117(2):193-199. doi: 10.1159/000506164. Epub 2020 May 8.
Results Reference
derived
Learn more about this trial
Non Invasive Ventilation Versus Continuous Positive Airway Pressure After Extubation of Very Low Birth Weight Infants.
We'll reach out to this number within 24 hrs